Polypharma: Generics Developer
  • Français
  • Deutsch
  • Home
  • Generics + Biosimilars
    • Product range
    • Human medicine
    • Veterinary medicine
    • Pharmaceutical raw materials
    • Laboratory supplies
  • Generics service
    • Full service to local production
    • Pharmaceutical raw material supply
    • Dossier development
    • Plant construction
    • Project planning
    • Technology transfer and registration service
    • New molecules
  • About us
    • Generics developer
    • Our Team
    • References + Milestones
    • Business ethics
  • Service request
Select Page

Rimegepant 75mg orodispersible tablet for migraine treatment

Mar 16, 2020 | Medicines

The US FDA has approved the Rimegepant 75mg orodispersible tablet.
The freeze-dried tablet should dissolve almost immediately in the mouth without water and provide a convenient, discreet way to take migraine medication.

https://www.cphi-online.com/catalent-partners-with-biohaven-on-newlyapproved-news082625.html?utm_campaign=HLN00CPO-GC-NewsletterWeek12&utm_emailname=HLN00CPO-GC-NewsletterWeek12&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=7124c9da-0506-4007-b30e-81ecc9c9c575&utm_campaigntype=Newsletter&utm_sub=Latest%20Pharma%20Supply%20Chain%20News&eM=72aa981ef401a1f83acaf77df3cd34f7e9bb75061f2959aa7de7caa55413825f&eventSeriesCode=ES_CPHLONL&eventEditionCode=HLN00CPO&SessionCode=S_CPHLONNWSLTR

BACK TO NEWS

Categories

  • Counterfeit Medicines (2)
  • Delivery difficulties (2)
  • Development / Dossiers (11)
  • Factory construction (3)
  • Fairs / Events (4)
  • Health (13)
  • Innovation (7)
  • Manufacturing Process (10)
  • Medicines (20)
  • Others (2)
  • Pharmaceutical Raw Materials / Laboratory Equipment (4)
  • Politics (2)
  • Registration Process (4)
Manage Cookie Consent
close
We use cookies to optimise our website and our service.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage third parties Manage vendors Read more about these purposes
Show settings
{title} {title} {title}